Advertisement

Topics

InB:Hauser Pharmaceuticals Services Inc Company Profile

14:25 EDT 21st June 2018 | BioPortfolio

InB:Hauser is a world leader in the extraction, isolation, purification and synthetic modification of natural products from plant, marine and microbial sources. InB:Hauser provides research, process development, analytical services, manufacturing, compliance services and consulting to produce compounds from natural raw materials for the pharmaceutical, dietary supplement and fine chemical industries

Location

6880 North Broadway, Suite H
Denver
Colorado
80221
United States of America

Contact

Phone: (720) 406-4700
Fax: (303) 412-8644
Email: problem.solving@hausercro.com


News Articles [790 Associated News Articles listed on BioPortfolio]

Jaguar Health, Inc.: Jaguar Health Subsidiary, Napo Pharmaceuticals, Signs Agreement with Pharmacy Services Provider "Transition Patient Services" to Establish Nationwide Pilot "Mytesi Direct" Program

SAN FRANCISCO, CA / ACCESSWIRE / March 2, 2018 / Jaguar Health, Inc. (NASDAQ: JAGX) (Jaguar or the Company), a commercial stage natural-products pharmaceuticals company focused on developing novel,...

Documo, Inc. Announces Equity Token Offering (ETO)

Documo had been privately funded with investors that include David Hauser, founder of Grasshopper (acquired by Citrix) and Chargify (acquired by ScaleWorks), and John Read more...

RSSL leads the way at Making Pharmaceuticals Europe

Reading Scientific Services Limited (RSSL), provider of analysis, training and consultancy solutions to the pharmaceutical, biopharmaceutical and healthcare industries will be attending Making Pharmac...

Primary Care Providers Have Mixed Views on Genetic Tests

FRIDAY, May 11, 2018 -- Primary care providers view tests for genetic risks of common diseases as useful, but lack confidence in interpreting results, according to a study published in the May issue o...

New Prestigious R&D Facility for Specialty Pharmaceuticals Expert

Boulting Environmental Services completes Indivior R&D facility build. Cleanroom and laboratory design and construction specialist, Boulting Environmental Services (BES) has completed a £13 ...

US continues to spend much more on health care than other countries, driven by prices of physician and hospital services, pharmaceuticals

(JAMA Network) The United States spent nearly twice as much as other high-income countries on medical care but did less well on many population health outcomes despite similar utilization.  Spending...

Critical Contrast: Ironwood Pharmaceuticals

Ironwood Pharmaceuticals and Infinity Pharmaceuticals are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, risk, d...

Hepatitis C Case, PTV News: May 10, 2010

Teva Pharmaceuticals and Baxter Healthcare Services told to pay US $500M damages

PubMed Articles [1059 Associated PubMed Articles listed on BioPortfolio]

Mayer-Rokitansky-Kuster-Hauser Syndrome: A Unique Case Presentation.

Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome is a congenital condition characterized by aplasia of the vagina with or without concurrent uterine and/or cervical aplasia. Type II (MURCS) is a rare fo...

The Interest of Women with Mayer-Rokitansky-Küster-Hauser Syndrome and Laparoscopic Vecchietti Neovagina in Uterus Transplantation.

The goal of this study was to assess a group of Mayer-Rokitansky-Küster-Hauser syndrome (MRKH) women with surgically created neovaginas in the interest of uterus transplantation (UTx) and to recruit ...

Combined laparoscopic and vaginal cervicovaginal reconstruction using acellular porcine small intestinal submucosa (SIS) graft in a patient with Mayer-Rokitansky-Küster-Hauser syndrome (U5aC4V4).

To introduce a creation that combines laparoscopic and Wharton-Sheares-George cervicovaginal reconstruction using SIS graft in a patient with Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome who had a ...

Ultrasound-guided follicle aspiration at time of laparotomy in a patient with Mayer-Rokitansky-Küster-Hauser syndrome.

To demonstrate a unique case of direct ultrasound-guided follicle aspiration at time of a laparotomy in a patient with Mayer-Rokitansky-Küster-Hauser Syndrome.

Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma.

Orlowski has received research funding from Amgen, BioTheryX, Bristol-Myers Squibb, Celgene Corporation, and Takeda Pharmaceuticals; honoraria from Amgen, Bristol-Myers Squibb, Celgene Corporation, Ja...

Clinical Trials [1225 Associated Clinical Trials listed on BioPortfolio]

Molecular Genetic Study of Mayer-Rokitansky-Kuster-Hauser Syndrome

In order to understand the molecular mechanisms leading to Mayer-Rokitansky-Kuster-Hauser syndrome (MRKH), the research team has to identify molecular bases of this anomaly. Toward this g...

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Companies [1909 Associated Companies listed on BioPortfolio]

InB:Hauser Pharmaceuticals Services Inc

InB:Hauser is a world leader in the extraction, isolation, purification and synthetic modification of natural products from plant, marine and microbial sources. InB:Hauser provides research, process d...

HAUSER GmbH

HAUSER's purpose is not just to sell refrigerated cabinets, but the core of HAUSER's philosophy is the use of Project Management to create an integrated system combining expert refrigeration engineeri...

HAUSER LABORATORIES

Hauser Laboratories is a research and development testing laboratory that provides research, development, testing, and expert witness services to the following industries: pharmaceutical, natural prod...

Zeta Pharmaceuticals Inc.

For those of you who know us as Zetapharm, the name of our company has been changed to Zeta Pharmaceuticals Inc. This reflects our acquiring the assets of Zetapharm from Hauser Inc. in late March 200...

Endress+Hauser Metso AG

Nil

More Information about "InB:Hauser Pharmaceuticals Services Inc" on BioPortfolio

We have published hundreds of InB:Hauser Pharmaceuticals Services Inc news stories on BioPortfolio along with dozens of InB:Hauser Pharmaceuticals Services Inc Clinical Trials and PubMed Articles about InB:Hauser Pharmaceuticals Services Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of InB:Hauser Pharmaceuticals Services Inc Companies in our database. You can also find out about relevant InB:Hauser Pharmaceuticals Services Inc Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record